What is the CVSS score of CVE-2024-38817?

CVE-2024-38817 has a CVSS 3.1 base score of 6.7 (Medium). CVSS vector: CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H. EPSS exploitation probability: 0.5%.

VMware CVE-2024-38817

MEDIUM

Command Injection (CWE-77)

2024-10-09 security@vmware.com

Command Injection VMware

6.7

CVSS 3.1 · Vendor: vmware

Severity by source

Vendor (vmware) PRIMARY

6.7 MEDIUM

AV:L/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H

Primary rating from Vendor (vmware) · only source for this CVE.

CVSS VectorVendor: vmware

CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H

Attack Vector

Local

Attack Complexity

Low

Privileges Required

High

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

High

Availability

High

Lifecycle Timeline

CVE Published

Oct 09, 2024 - 20:15 cve.org

MEDIUM 6.7

DescriptionCVE.org

VMware NSX contains a command injection vulnerability.

A malicious actor with access to the NSX Edge CLI terminal may be able to craft malicious payloads to execute arbitrary commands on the operating system as root.

AnalysisAI

VMware NSX contains a command injection vulnerability. Rated medium severity (CVSS 6.7), this vulnerability is low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified as Command Injection (CWE-77), which allows attackers to inject arbitrary commands into system command execution. VMware NSX contains a command injection vulnerability. A malicious actor with access to the NSX Edge CLI terminal may be able to craft malicious payloads to execute arbitrary commands on the operating system as root.

Affected ProductsAI

See vendor advisory for affected versions.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Use parameterized APIs, avoid shell execution, validate input with strict allowlists.